These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9665502)

  • 1. Low dihydrotestosterone and weight loss in the AIDS wasting syndrome.
    Sattler F; Briggs W; Antonipillai I; Allen J; Horton R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):246-51. PubMed ID: 9665502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss.
    Arver S; Sinha-Hikim I; Beall G; Guerrero M; Shen R; Bhasin S
    J Androl; 1999; 20(5):611-8. PubMed ID: 10520573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.
    Grinspoon S; Corcoran C; Parlman K; Costello M; Rosenthal D; Anderson E; Stanley T; Schoenfeld D; Burrows B; Hayden D; Basgoz N; Klibanski A
    Ann Intern Med; 2000 Sep; 133(5):348-55. PubMed ID: 10979879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hormones in men with human immunodeficiency virus-associated wasting.
    Dobs AS; Few WL; Blackman MR; Harman SM; Hoover DR; Graham NM
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4108-12. PubMed ID: 8923868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
    Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
    Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. So similar and so different: Circulating androgens and androgen origin in bulimic women.
    Naessén S; Söderqvist G; Carlström K
    J Steroid Biochem Mol Biol; 2019 Jan; 185():184-188. PubMed ID: 30172682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
    JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction.
    Yeap BB; Alfonso H; Chubb SA; Hankey GJ; Handelsman DJ; Golledge J; Almeida OP; Flicker L; Norman PE
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4565-73. PubMed ID: 25268392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.
    Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
    J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential associations of testosterone, dihydrotestosterone and oestradiol with physical, metabolic and health-related factors in community-dwelling men aged 17-97 years from the Busselton Health Survey.
    Yeap BB; Knuiman MW; Divitini ML; Handelsman DJ; Beilby JP; Beilin J; McQuillan B; Hung J
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):100-8. PubMed ID: 24428256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive impairment of testicular endocrine function in ageing men: Testosterone and dihydrotestosterone decrease, and luteinizing hormone increases, in men transitioning from the 8th to 9th decades of life.
    Yeap BB; Manning L; Chubb SAP; Handelsman DJ; Almeida OP; Hankey GJ; Flicker L
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):88-95. PubMed ID: 28945276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.
    Gustafsson O; Norming U; Gustafsson S; Eneroth P; Aström G; Nyman CR
    Br J Urol; 1996 Mar; 77(3):433-40. PubMed ID: 8814852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.